1. Home
  2. Live Updates
  3. Hormone products

Live Breaking News & Updates on Hormone products

Stay informed with the latest breaking news from Hormone products on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Hormone products and stay connected to the pulse of your community

VTv Therapeutics Shares Surge on $51 Million Private Placement

By Josh Beckerman Shares of vTv Therapeutics more than doubled after the company raised $51 million in a private placement, which will be used to fund the...

Josh-beckerman , D-fund , Samsara-biocapital , Article-normal , Pharmaceuticals , Healthcare-life-sciences , Specialized-drugs-medications , Hormone-products , Diabetes-drugs , Financial-performance , Share-price-movement-disruptions

Viking Therapeutics' stock soars 61% premarket after company reports positive results in trial of weight-loss drug

Viking posted positive results from a mid-stage trial of its GLP-1 drug.

Drug-administration , Therapeutics-inc , Viking-therapeutics , Article-normal , Biotechnology , Pharmaceuticals , Machinery , Agricultural-machinery , Health-care , Biopharmaceuticals , Specialized-drugs-medications

Viking Therapeutics' stock doubles as investors cheer cheap entry to weight-loss drug craze

Viking posted positive results from a mid-stage trial of its GLP-1 drug.

Therapeutics-inc , Viking-therapeutics , Article-normal , Biotechnology , Pharmaceuticals , Machinery , Agricultural-machinery , Health-care , Biopharmaceuticals , Specialized-drugs-medications , Hormone-products

Viking Therapeutics' stock benefits as investors cheer weight-loss-drug results

Viking posted positive results from a mid-stage trial of its GLP-1 drug.

Therapeutics-inc , Viking-therapeutics , Article-normal , Biotechnology , Pharmaceuticals , Machinery , Agricultural-machinery , Health-care , Biopharmaceuticals , Specialized-drugs-medications , Hormone-products

Biote Up 15% on Settlement and Repurchase Agreement With Founder Gary S. Donovitz

By Josh Beckerman Biote shares rose 15% Wednesday as the company agreed to settle litigation with founder and stockholder Gary S. Donovitz. The stock was...

Dallas , Texas , United-states , Garys-donovitz , Josh-beckerman , Biote-holdings , Haymaker-acquisition-corp , Dallas-morning-news , Haymaker-acquisition , Article-normal , Pharmaceuticals , Healthcare-life-sciences

Wegovy Maker Novo Nordisk's Success Fuels Investment Growth for Its Controlling Shareholder

By Dominic Chopping The success of Novo Nordisk's blockbuster weight-loss and diabetes drugs will help boost income at the company's controlling shareholder,...

Christoffer-soderberg , Novo-holdings , Novo-nordisk-foundation , Novo-holding , Novo-nordisk , New-york-listed , Managing-partner , Principal-investments , Dominic-chopping , Article-normal , Pharmaceuticals , Trusts-funds-financial-vehicles

Embecta Shares Fall Despite Outlook Raise, Strong 1Q

By Dean Seal Shares of Embecta fell despite the company raising its full-year outlook and recording better-than-expected results in its fiscal first quarter....

Dean-seal , Article-normal , Pharmaceuticals , Healthcare-life-sciences , Specialized-drugs-medications , Hormone-products , Diabetes-drugs , Financial-performance , Share-price-movement-disruptions , Corporate-industrial-news , Equity-markets

Eli Lilly's stock surges toward a 5th straight record after an earnings beat and upbeat outlook

U.S. prices for Lilly’s drugs climbed 27%, driven by diabetes treatment Mounjaro, while prices outside the U.S. fell.

Eli-lilly , Article-normal , Weightloss , Diabetes , Pharmaceuticals , Machinery , Agricultural-machinery , Health-care , Specialized-drugs-medications , Hormone-products , Industrial-goods

Eli Lilly Reports Earnings Tuesday. What to Expect.

Drugmaker Eli Lilly will give investors a first glimpse at sales figures for Zepbound, its new obesity medicine, on Tuesday when it releases its...

David-ricks , Josh-nathan-kazis , Eli-lilly , Novo-nordisk , Pfizer , Article-normal , Pharmaceuticals , Machinery , Agricultural-machinery , Healthcare-life-sciences , Specialized-drugs-medications , Hormone-products

Bumper profits for Norway's wealth fund led by tech companies

Norway's oil fund reported the largest annual return in its history Tuesday, a performance led by U.S. technology companies and Danish pharmaceutical company...

Norway , Denmark , Danish , Nicolai-tangen , Nova-nordisk , Nvidia , Novo-nordisk , Oil-fund , Government-pension-fund-global , Microsoft , Norway-government-pension-fund-global , Article-normal